Michael R. Simon active positions
| Companies | Position | Start | End |
|---|---|---|---|
Secretory IgA, Inc.
 Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Founder | 20/09/2011 | - |
| President | 20/09/2011 | - | |
| Wayne State University (Michigan) | Corporate Officer/Principal | 20/09/2011 | - |
Career history of Michael R. Simon
Training of Michael R. Simon
| New York University | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Founder | 1 |
| President | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Secretory IgA, Inc.
Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Health Technology |
- Stock Market
- Insiders
- Michael R. Simon
- Experience
